CK Life Sciences Int'l., (Holdings) Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 1,925

Employees

  • Stock Symbol
  • 00775

Stock Symbol

  • Investments
  • 19

  • Share Price
  • $0.07
  • (As of Monday Closing)

CK Life Sciences Int'l., (Holdings) General Information

Description

CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 2 Dai Fu Street
  • Tai Po Industrial Estate
  • Hong Kong
  • Hong Kong
+852 2126
Primary Industry
Holding Companies
Other Industries
Biotechnology
Stock Exchange
HKG
Corporate Office
  • 2 Dai Fu Street
  • Tai Po Industrial Estate
  • Hong Kong
  • Hong Kong
+852 2126

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CK Life Sciences Int'l., (Holdings) Stock Performance

As of 16-Nov-2026, CK Life Sciences Int'l., (Holdings)’s stock price is $0.07. Its current market cap is $643M with 9.6B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.07 $0.07 $0.06 - $0.12 $643M 9.6B 3.47M

CK Life Sciences Int'l., (Holdings) Financials Summary

As of 30-Jun-2026, CK Life Sciences Int'l., (Holdings) has a trailing 12-month revenue of $707M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,474,695 1,745,172 1,201,088 1,458,121
Revenue 706,613 693,948 707,739 679,856
EBITDA 39,657 60,669 61,124 78,114
Net Income (8,282) (23,961) (16,218) 2,203
Total Assets 1,551,458 1,521,126 1,389,653 1,439,337
Total Debt 871,314 850,899 785,685 759,007
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CK Life Sciences Int'l., (Holdings) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CK Life Sciences Int'l., (Holdings)‘s full profile, request access.

Request a free trial

CK Life Sciences Int'l., (Holdings) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CK Life Sciences Int'l., (Holdings) Investments & Acquisitions (19)

CK Life Sciences Int'l., (Holdings)’s most recent deal was a Early Stage VC with PharusDx for . The deal was made on 30-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharusDx 30-Apr-2025 Early Stage VC Biotechnology
PharusDx 25-Jul-2022 Early Stage VC Biotechnology
Nangiloc Colignan Farm (Farm Assets) 01-Dec-2018 Corporate Asset Purchase Buildings and Property
Polynoma 16-Nov-2017 Merger/Acquisition Drug Discovery
Optigen Ingredients 01-Jan-2014 Merger/Acquisition Specialty Chemicals
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

CK Life Sciences Int'l., (Holdings) ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

30.21 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view CK Life Sciences Int'l., (Holdings)’s complete esg history, request access »

CK Life Sciences Int'l., (Holdings) Exits (6)

CK Life Sciences Int'l., (Holdings)’s most recent exit was on 16-Nov-2017 from Polynoma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Polynoma 16-Nov-2017 Completed
Optigen Ingredients 01-Jan-2014 Completed
WEX Pharmaceuticals 05-May-2011 Completed
WEX Pharmaceuticals 18-Oct-2009 Completed
WEX Pharmaceuticals 17-Oct-2007 PIPE Completed
You’re viewing 5 of 6 exits. Get the full list »

CK Life Sciences Int'l., (Holdings) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Lipa Pharmaceuticals Minto, Australia 1995
Cheetham Salt Melbourne, Australia 1888

CK Life Sciences Int'l., (Holdings) FAQs

  • When was CK Life Sciences Int'l., (Holdings) founded?

    CK Life Sciences Int'l., (Holdings) was founded in 1999.

  • Where is CK Life Sciences Int'l., (Holdings) headquartered?

    CK Life Sciences Int'l., (Holdings) is headquartered in Hong Kong, Hong Kong.

  • What is the size of CK Life Sciences Int'l., (Holdings)?

    CK Life Sciences Int'l., (Holdings) has 1,925 total employees.

  • What industry is CK Life Sciences Int'l., (Holdings) in?

    CK Life Sciences Int'l., (Holdings)’s primary industry is Holding Companies.

  • Is CK Life Sciences Int'l., (Holdings) a private or public company?

    CK Life Sciences Int'l., (Holdings) is a Public company.

  • What is CK Life Sciences Int'l., (Holdings)’s stock symbol?

    The ticker symbol for CK Life Sciences Int'l., (Holdings) is 00775.

  • What is the current stock price of CK Life Sciences Int'l., (Holdings)?

    As of 16-Nov-2026 the stock price of CK Life Sciences Int'l., (Holdings) is $0.07.

  • What is the current market cap of CK Life Sciences Int'l., (Holdings)?

    The current market capitalization of CK Life Sciences Int'l., (Holdings) is $643M.

  • What is CK Life Sciences Int'l., (Holdings)’s current revenue?

    The trailing twelve month revenue for CK Life Sciences Int'l., (Holdings) is $707M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process